Waldron Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-422
Closed -$211K 403
2023
Q1
$211K Buy
+422
New +$202K 0.01% 384
2021
Q3
Sell
-356
Closed -$224K 365
2021
Q2
$224K Buy
+356
New +$197K 0.01% 311

Other funds holding IDXX

Waldron Private Wealth's IDXX Position: Q2 2023 in Review

Waldron Private Wealth sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 422 shares — an estimated $211K sold.

Waldron Private Wealth first reported a position in IDXX in Q2 2021 and held it in 2 quarters. The position peaked at $224K in Q2 2021. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

  • Waldron Private Wealth reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
  • Waldron Private Wealth sold 422 Idexx Laboratories shares in Q2 2023, an estimated $211K.
  • Waldron Private Wealth first reported a position in Idexx Laboratories in Q2 2021 and held it in 2 quarters.
  • Waldron Private Wealth's Idexx Laboratories position peaked at $224K in Q2 2021.
  • 1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Waldron Private Wealth's 13F filing for Q2 2023, filed 7 Aug 2023.